Day: October 16, 2026

Written and medically reviewed by David Nazarian, MD — Board Certified in Internal Medicine and Medical Director of PRP Treatment Beverly Hills. Last medically reviewed: October 2026.

Quick answer: Both platelet-rich plasma (PRP) and hyaluronic acid (HA) injections are used in nonsurgical management of knee osteoarthritis. Recent randomized-trial meta-analyses generally report greater average improvement in pain and function with PRP than HA at medium-term follow-up, but results vary by PRP preparation, osteoarthritis severity, number of injections, and study quality.

What is hyaluronic acid?

Hyaluronic acid is a naturally occurring component of synovial fluid. Injectable HA products are used as viscosupplementation with the goal of improving joint lubrication and symptoms. Products differ in molecular weight, formulation, and injection schedule.

How is PRP different?

PRP is prepared from the patient’s own blood and contains concentrated platelets and associated signaling proteins. It does not work as a lubricant. Its proposed effects involve modulation of local inflammatory and cellular signaling, although the exact clinical mechanism remains uncertain.

What do recent studies show?

Several recent systematic reviews of randomized controlled trials have found better average WOMAC and pain outcomes with PRP compared with HA, especially at 6 to 12 months. A 2025 systematic review including 42 randomized trials favored PRP over HA for several pain and function outcomes, while a 2026 network meta-analysis found both leukocyte-rich and leukocyte-poor PRP superior to placebo for function at 6 to 12 months. These are group averages and do not guarantee an individual response.

Is one always better?

No. Patient age, osteoarthritis severity, inflammatory pattern, previous injections, expectations, cost, contraindications, and clinician experience all matter. Guidelines also differ in how strongly they recommend or discourage various injection options.

What about combining PRP and HA?

Combination therapy has also been studied. A 2024 meta-analysis reported better outcomes for PRP plus HA compared with HA alone, but no clear superiority over PRP alone. That does not establish combination therapy as necessary or standard for every patient.

My approach

I first confirm that knee osteoarthritis is actually the main pain generator and review disease severity, prior treatment, function, imaging, rehabilitation, and expectations. The decision between PRP, HA, corticosteroid, or another approach should come after that evaluation.

Related: PRP knee injections, PRP vs cortisone, and how I decide whether PRP is worth doing.

Medical references

• 2025 systematic review of PRP versus hyaluronic acid for knee osteoarthritis
• 2025 meta-analysis of leukocyte-poor PRP versus hyaluronic acid
• 2026 network meta-analysis of PRP, hyaluronic acid, and placebo

Written and medically reviewed by David Nazarian, MD — Board Certified in Internal Medicine and Medical Director of PRP Treatment Beverly Hills. Last medically reviewed: October 2026.

Quick answer: PRP and corticosteroid injections are not interchangeable. Corticosteroid injections can reduce inflammation and pain relatively quickly in selected conditions, while PRP is an autologous platelet-based treatment with a different mechanism and a slower, less predictable response. Which option makes sense depends on the diagnosis, treatment goal, evidence for that condition, and the patient’s medical history.

How PRP and cortisone differ

Feature	PRP	Corticosteroid injection
What is injected?	Platelet-rich plasma prepared from the patient’s blood	Anti-inflammatory corticosteroid medication
Main goal	Investigational biologic modulation of local tissue response	Reduce inflammation and pain
Onset	Usually gradual if benefit occurs	Often faster symptom relief
Evidence	Varies substantially by diagnosis	Established for selected inflammatory and musculoskeletal uses
Durability	Condition-dependent and uncertain	May be temporary; repeated use requires clinical judgment

What does the evidence show?

For knee osteoarthritis, recent systematic reviews of randomized trials suggest both PRP and corticosteroid injections can improve symptoms, with some analyses reporting more sustained improvement after PRP. However, PRP preparations, injection schedules, and study methods vary, and this does not mean PRP is superior for every joint or tendon problem.

What about tendon injuries?

The answer depends on the tendon. Corticosteroid injections may provide short-term pain relief in some conditions but can have limitations with repeated use around certain tendons. PRP evidence is mixed and condition-specific. For lateral epicondylitis, for example, recent placebo-controlled evidence has not shown a consistent benefit from PRP.

When might cortisone be preferred?

A corticosteroid injection may be considered when rapid anti-inflammatory symptom relief is appropriate and the expected benefit outweighs the risks. The underlying diagnosis, tissue being injected, frequency of prior injections, diabetes, infection risk, and other factors matter.

When might PRP be discussed?

PRP may be discussed when evidence supports its use for the specific condition, conservative care has not been sufficient, and the patient understands that benefit is not guaranteed. I prefer to compare PRP with the best-established alternatives rather than present it as a universally more “natural” or superior injection.

Related: How I decide whether PRP is worth doing, PRP knee injections, and PRP for tendon and sports injuries.

Medical references

• 2025 systematic review of PRP versus corticosteroid injections for knee osteoarthritis
• 2025 review comparing the evidence base for corticosteroid and PRP injections in knee osteoarthritis

Written and medically reviewed by David Nazarian, MD — Board Certified in Internal Medicine and Medical Director of PRP Treatment Beverly Hills. Last medically reviewed: October 2026.

My approach: I do not start with the question, “Can PRP be injected here?” I start with, “What is the diagnosis, what does the evidence show for this diagnosis, what has already been tried, and is PRP likely to add meaningful value compared with established options?”

Step 1: Confirm the diagnosis

PRP is not one treatment for every painful joint, tendon problem, hair-loss pattern, aesthetic concern, or sexual-health symptom. The same symptom can have very different causes. Examination, prior records, laboratory testing, ultrasound, X-ray, MRI, or specialist evaluation may be appropriate depending on the concern.

Step 2: Ask how strong the evidence is for that indication

The evidence for PRP varies substantially by condition. There is stronger evidence for some applications than others, while several uses remain investigational. I prefer to explain that difference directly rather than treating every PRP indication as equally established.

Step 3: Compare PRP with established alternatives

The meaningful question is not simply whether PRP can help. It is whether PRP makes sense compared with rehabilitation, medication, another injection, surgery, hormone treatment, hair-loss medication, or another evidence-based option.

Step 4: Look at the patient, not just the procedure

Age, disease severity, medical conditions, medications, platelet or bleeding issues, treatment goals, previous response to therapy, and willingness to participate in rehabilitation can all affect whether PRP is a reasonable option.

Step 5: Define what success would actually mean

Before treatment, I want a clear goal: less pain, better function, improved hair density, or another measurable outcome. If there is no meaningful benefit, repeating a procedure indefinitely is not a treatment plan.

When I would tell a patient not to do PRP

I would advise against PRP when the diagnosis is unclear, when another treatment is better supported, when surgery is clearly indicated, when the expected benefit is too uncertain for the cost and burden, or when a medical contraindication makes the procedure inappropriate.

Explore our general PRP guide, what to expect at a PRP visit, and PRP pricing.

Written and medically reviewed by David Nazarian, MD — Board Certified in Internal Medicine and Medical Director of PRP Treatment Beverly Hills. Last medically reviewed: October 2026.

Quick answer: Platelet-rich plasma has been studied in women with sexual-function concerns, including arousal and orgasm domains, but the evidence is still too limited to predict who will benefit or to recommend PRP as a standard treatment for orgasmic difficulty or reduced arousal.

What does female arousal involve?

Arousal is influenced by genital blood flow and sensation, but also by desire, hormonal state, medications, pain, pelvic-floor function, mood, relationship factors, neurologic function, and context. Orgasm likewise depends on multiple physiologic and psychological pathways.

What has PRP research measured?

Some small studies use validated sexual-function questionnaires that include arousal, lubrication, orgasm, satisfaction, and pain. Improvements have been reported in selected studies, but the literature is small and heterogeneous.

Why a diagnosis matters before an injection

If arousal or orgasm changed after menopause, childbirth, pelvic surgery, a new medication, antidepressant therapy, onset of pain, or neurologic disease, the appropriate treatment may be very different. A single procedure should not be assumed to address every cause.

What else may need to be considered?

• Medication review
• Hormonal evaluation when clinically indicated
• Pelvic-floor therapy
• Treatment of vaginal dryness or pain
• Sex therapy or couples therapy
• Neurologic or gynecologic evaluation when appropriate

See our platelet-rich plasma for female sexual dysfunction page and our guide to PRP for orgasm difficulty and reduced genital sensation.

Important: Vaginal PRP and platelet-rich plasma for female sexual dysfunction remain investigational/off-label. Evidence is limited and heterogeneous, and these treatments should not be presented as proven cures or replacements for established evaluation and treatment.

Medical references

• Systematic review of PRP for female sexual dysfunction and stress urinary incontinence
• Cleveland Clinic overview of sexual-health PRP procedures and evidence limitations

Written and medically reviewed by David Nazarian, MD — Board Certified in Internal Medicine and Medical Director of PRP Treatment Beverly Hills. Last medically reviewed: October 2026.

Quick answer: Vaginal PRP has been explored for menopausal sexual symptoms, including dryness and discomfort, but it is not an established treatment for genitourinary syndrome of menopause (GSM). Standard treatments for GSM have a stronger evidence base and should be considered first or alongside investigational options.

Why menopause affects vaginal and sexual health

Lower estrogen levels can contribute to vaginal dryness, reduced lubrication, tissue changes, urinary symptoms, discomfort with intercourse, and changes in sexual function. These symptoms fall within the broader diagnosis of genitourinary syndrome of menopause.

What has vaginal PRP been studied for?

Small studies have reported improvement in vaginal-health or sexual-function scores after PRP, but study quality is limited, protocols differ, and many studies do not compare PRP against the best-established standard therapies.

What established treatments should be discussed?

Depending on the patient, options may include vaginal moisturizers and lubricants, low-dose vaginal estrogen, vaginal prasterone, ospemifene, pelvic-floor therapy, treatment of vulvar or pain disorders, and systemic menopausal hormone therapy when appropriate for broader symptoms.

Where PRP may fit

PRP can be discussed as an investigational adjunct for a carefully counseled patient who understands the uncertainty. It should not be presented as a replacement for diagnosis or standard menopause care.

Related: PRP for vaginal dryness and our vaginal PRP hub.

Important: Vaginal PRP and platelet-rich plasma for female sexual dysfunction remain investigational/off-label. Evidence is limited and heterogeneous, and these treatments should not be presented as proven cures or replacements for established evaluation and treatment.

Medical references

• Systematic review of PRP for female sexual dysfunction and stress urinary incontinence
• Cleveland Clinic overview of sexual-health PRP procedures and evidence limitations

Written and medically reviewed by David Nazarian, MD — Board Certified in Internal Medicine and Medical Director of PRP Treatment Beverly Hills. Last medically reviewed: October 2026.

Quick answer: Vaginal PRP pricing varies by practice, protocol, number of injection sites, number of sessions, and whether consultation or follow-up is included. Because protocols are not standardized, price alone does not tell you whether two treatments are equivalent.

What can affect vaginal PRP cost?

• Number of treatment sessions
• PRP preparation system
• Number and location of injection sites
• Whether pelvic or sexual-health evaluation is included
• Use of adjunctive therapies
• Follow-up and reassessment

Why the cheapest option is not necessarily comparable

PRP concentration, preparation, injection technique, and physician evaluation can differ substantially from one office to another. A lower price may reflect a different protocol rather than the same treatment at a discount.

Should insurance cover vaginal PRP?

Because PRP for female sexual dysfunction is investigational and not an established FDA-approved indication, it is commonly self-pay. Patients should verify coverage directly if they want to know whether any portion of evaluation or treatment may be reimbursable.

What should you ask before paying for treatment?

• What diagnosis is being treated?
• What evidence supports this use?
• How many sessions are recommended and why?
• What outcome will be measured?
• What happens if there is no improvement?
• What established alternatives should also be considered?

See our main vaginal PRP page for the medical overview.

Important: Vaginal PRP and platelet-rich plasma for female sexual dysfunction remain investigational/off-label. Evidence is limited and heterogeneous, and these treatments should not be presented as proven cures or replacements for established evaluation and treatment.

Medical references

• Systematic review of PRP for female sexual dysfunction and stress urinary incontinence
• Cleveland Clinic overview of sexual-health PRP procedures and evidence limitations

Written and medically reviewed by David Nazarian, MD — Board Certified in Internal Medicine and Medical Director of PRP Treatment Beverly Hills. Last medically reviewed: October 2026.

Quick answer: There is no standardized “before and after” outcome for vaginal PRP because protocols, symptoms, outcome measures, and follow-up periods vary widely. Published studies typically use validated symptom questionnaires rather than a visible cosmetic transformation.

What does “results” mean for vaginal PRP?

Depending on the study, improvement may refer to changes in arousal, lubrication, orgasm, pain, satisfaction, genital sensation, or urinary symptoms. These are patient-reported functional outcomes—not a uniform visual before-and-after result.

How soon might changes be noticed?

Published protocols vary, and there is no evidence-based timeline that applies to every patient. Some studies assess outcomes within weeks to a few months. Long-term durability remains uncertain.

Why before-and-after marketing can be misleading

Unlike a cosmetic procedure where a photograph may capture the main outcome, sexual function is multifactorial. A patient’s response can depend on hormonal status, medications, pelvic-floor function, pain, sleep, mood, relationships, and neurologic factors.

What I consider a meaningful result

A meaningful result should be improvement in the symptom that matters to the patient, measured against baseline, while also considering whether an established therapy would be more appropriate. If no meaningful benefit occurs, treatment should be reconsidered rather than repeatedly continued without evidence of response.

Related: vaginal PRP benefits and platelet-rich plasma for female sexual dysfunction.

Important: Vaginal PRP and platelet-rich plasma for female sexual dysfunction remain investigational/off-label. Evidence is limited and heterogeneous, and these treatments should not be presented as proven cures or replacements for established evaluation and treatment.

Medical references

• Systematic review of PRP for female sexual dysfunction and stress urinary incontinence
• Cleveland Clinic overview of sexual-health PRP procedures and evidence limitations

Written and medically reviewed by David Nazarian, MD — Board Certified in Internal Medicine and Medical Director of PRP Treatment Beverly Hills. Last medically reviewed: October 2026.

Quick answer: Potentially reported benefits of vaginal PRP in small studies include improvement in some measures of sexual function, lubrication, orgasm, pain, or urinary symptoms. However, the evidence is not strong enough to guarantee benefit, define the ideal candidate, or establish vaginal PRP as a standard treatment.

What benefits are being studied?

Researchers have evaluated platelet-rich plasma for female sexual dysfunction using questionnaires that measure desire, arousal, lubrication, orgasm, satisfaction, and pain. Some studies have also evaluated stress urinary incontinence and vaginal-health outcomes.

What vaginal PRP does not reliably promise

• A guaranteed increase in orgasm
• A permanent increase in genital sensation
• A cure for painful intercourse
• A proven treatment for menopausal vaginal dryness
• A guaranteed treatment for urinary leakage

Why results may differ from one woman to another

Female sexual symptoms can be driven by menopause, medications, pelvic-floor dysfunction, neurologic conditions, pain disorders, relationship factors, psychological factors, or a combination. A biologic injection may not address the dominant cause.

How I discuss expected benefit

I frame vaginal PRP as an investigational option. The most important part of the visit is deciding whether the symptom is likely hormonal, pelvic-floor, neurologic, pain-related, medication-related, or multifactorial. That determines whether PRP is even a reasonable discussion.

Start with our vaginal PRP and platelet-rich plasma for female sexual dysfunction hub.

Important: Vaginal PRP and platelet-rich plasma for female sexual dysfunction remain investigational/off-label. Evidence is limited and heterogeneous, and these treatments should not be presented as proven cures or replacements for established evaluation and treatment.

Medical references

• Systematic review of PRP for female sexual dysfunction and stress urinary incontinence
• Cleveland Clinic overview of sexual-health PRP procedures and evidence limitations

Written and medically reviewed by David Nazarian, MD — Board Certified in Internal Medicine and Medical Director of PRP Treatment Beverly Hills. Last medically reviewed: October 2026.

Quick answer: PRP has been explored in small studies involving female sexual dysfunction and pain with intercourse, but evidence is not strong enough to consider it an established treatment for dyspareunia. Painful sex has many possible causes, and identifying the cause is essential.

Common causes of painful intercourse

• Genitourinary syndrome of menopause and vaginal dryness
• Pelvic-floor muscle spasm or dysfunction
• Vulvodynia or vestibulodynia
• Infection or inflammation
• Endometriosis or pelvic pathology
• Dermatologic conditions
• Postpartum injury or scarring
• Psychological and relationship factors

What does PRP research show?

Some small studies and combination-treatment studies report improvement in pain or sexual-function scores, but the literature is heterogeneous and often combines PRP with other interventions. That makes it difficult to know how much benefit, if any, comes from PRP itself.

What should happen before considering PRP?

A clinician should first determine whether the pain is superficial or deep, whether dryness or hormonal changes are present, and whether pelvic-floor, infectious, dermatologic, or gynecologic causes need targeted treatment.

For related symptoms, see PRP and vaginal dryness and the main female sexual-function PRP page.

Important: PRP for sexual-function concerns is investigational/off-label. Evidence is limited and heterogeneous, and PRP should not be presented as a proven cure or replacement for established evaluation and treatment.

Medical references

• Systematic review of PRP for female sexual dysfunction and stress urinary incontinence
• Cleveland Clinic overview of sexual-health PRP procedures and evidence limitations

Written and medically reviewed by David Nazarian, MD — Board Certified in Internal Medicine and Medical Director of PRP Treatment Beverly Hills. Last medically reviewed: October 2026.

Quick answer: PRP injections have been studied experimentally for female stress urinary incontinence, but evidence remains limited and does not replace established evaluation or treatments such as pelvic-floor muscle therapy, pessary options, or surgery when appropriate.

What is stress urinary incontinence?

Stress urinary incontinence is leakage with activities that increase abdominal pressure, such as coughing, laughing, sneezing, running, or lifting. It is different from urgency incontinence, although some women have both.

What has PRP research found?

A systematic review identified several small studies of periurethral PRP for female stress urinary incontinence. Some reported improvement in symptom scores, but evidence quality was low. In the randomized study included in that review, midurethral sling surgery produced stronger outcomes than PRP on several validated measures.

Why the diagnosis matters

Urinary leakage can result from stress incontinence, overactive bladder, infection, pelvic organ prolapse, neurologic disease, medication effects, or a combination. Treatment depends on the type and severity.

Established options

Pelvic-floor muscle training is often a first-line approach. Other options can include pessaries, continence devices, urethral bulking agents, or surgical procedures depending on the patient. PRP should be discussed only with clear counseling that it remains investigational.

See our PRP for female sexual dysfunction overview.

Important: PRP for sexual-function concerns is investigational/off-label. Evidence is limited and heterogeneous, and PRP should not be presented as a proven cure or replacement for established evaluation and treatment.

Medical references

• Systematic review of PRP for female sexual dysfunction and stress urinary incontinence
• Cleveland Clinic overview of sexual-health PRP procedures and evidence limitations